Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KULTURBIOGRAFEN A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   2.8% 2.8% 2.8% 2.8% 2.8% 2.8% 2.8% 2.8%   Bankruptcy risk   1.4% 1.2% 3.2% 2.8% 1.5% 1.4% 9.3% 9.3%   Credit score (0-100)   80 82 55 57 75 77 26 26   Credit rating   A A BBB BBB A A BB BB   Credit limit (kDKK)   58.9 167.1 0.0 0.0 20.4 61.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,990 6,332 3,751 3,629 4,816 5,350 0.0 0.0   EBITDA   2,482 2,668 711 821 1,554 2,408 0.0 0.0   EBIT   1,921 2,070 122 252 975 1,843 0.0 0.0   Pre-tax profit (PTP)   1,455.7 1,699.7 -80.2 15.9 735.3 1,555.3 0.0 0.0   Net earnings   1,453.3 1,464.3 -131.2 -99.7 665.3 1,492.1 0.0 0.0   Pre-tax profit without non-rec. items   1,456 1,700 -80.2 15.9 735 1,555 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   19,223 18,672 18,083 17,592 17,081 16,515 0.0 0.0   Shareholders equity total   5,816 6,917 4,786 4,686 5,352 6,178 2,686 2,686   Interest-bearing liabilities   10,545 9,070 9,306 9,364 9,052 8,075 0.0 0.0   Balance sheet total (assets)   20,611 19,590 18,750 18,211 17,939 17,170 2,686 2,686   Net Debt   10,531 9,054 9,286 9,361 9,045 8,056 -2,686 -2,686     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,990 6,332 3,751 3,629 4,816 5,350 0.0 0.0   Gross profit growth   8.1% 5.7% -40.8% -3.3% 32.7% 11.1% -100.0% 0.0%   Employees   0 0 7 6 7 7 0 0   Employee growth %   -100.0% 0.0% 0.0% -14.3% 16.7% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   20,611 19,590 18,750 18,211 17,939 17,170 2,686 2,686   Balance sheet change%   2.6% -5.0% -4.3% -2.9% -1.5% -4.3% -84.4% 0.0%   Added value   2,481.5 2,667.7 711.5 821.1 1,544.6 2,408.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -487 -1,148 -1,179 -1,060 -1,091 -1,130 -16,515 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 5.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   32.1% 32.7% 3.2% 6.9% 20.3% 34.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.5% 10.8% 0.6% 1.4% 5.4% 10.5% 0.0% 0.0%   ROI %   11.1% 13.0% 0.8% 1.7% 6.4% 12.1% 0.0% 0.0%   ROE %   28.6% 23.0% -2.2% -2.1% 13.3% 25.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   28.2% 35.3% 25.5% 25.7% 29.8% 36.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   424.4% 339.4% 1,305.1% 1,140.1% 581.9% 334.5% 0.0% 0.0%   Gearing %   181.3% 131.1% 194.4% 199.8% 169.1% 130.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.0% 4.8% 2.2% 2.5% 2.6% 3.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.0   Current Ratio   0.2 0.2 0.1 0.1 0.2 0.1 0.0 0.0   Cash and cash equivalent   13.8 16.2 19.7 3.5 6.9 18.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -5,475.5 -3,673.8 -5,628.0 -5,590.1 -4,815.9 -3,838.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 102 137 221 344 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 102 137 222 344 0 0   EBIT / employee   0 0 17 42 139 263 0 0   Net earnings / employee   0 0 -19 -17 95 213 0 0